U.S. Personal Products Stock News

Insulet (PODD) just put up third quarter FY 2025 numbers with revenue of US$706.3 million and basic EPS of US$1.24, alongside net income of US$87.6 million, setting the tone for how the rest of the year is shaping up. The company has seen revenue move from US$488.5 million in Q2 2024 to US$649.1 million in Q2 2025 and US$706.3 million in Q3 2025, while basic EPS shifted from US$2.69 to US$0.32 and then US$1.24 over the same quarters. This gives investors a clear view of how the top line and...

If you are wondering whether OneMain Holdings at around US$56.83 is pricing in too much risk or leaving value on the table, you are asking the right question. The stock has had a mixed run, with a 5.3% decline over the last 7 days and a 13.1% decline over the last 30 days, even though the 1 year, 3 year and 5 year returns sit at 7.4%, 69.2% and 78.4% respectively. These moves come as investors continue to reassess consumer credit exposure and funding conditions for personal lenders like...

Caesars Entertainment (CZR) closed out FY 2025 with fourth quarter revenue of US$2.9 billion, a basic EPS loss of US$1.23 and a net income loss of US$250 million, compared with revenue of US$2.8 billion, basic EPS of US$0.05 and net income of US$11 million in the same quarter a year earlier. Over the past year, the company has seen quarterly revenue range from US$2.8 billion to US$2.9 billion, while basic EPS moved from a US$0.27 loss in Q3 2025 to a US$1.23 loss in Q4 2025. Trailing twelve...

Hapag Lloyd has agreed to acquire ZIM Integrated Shipping Services (NYSE:ZIM) in a US$4.2b transaction. The deal includes the creation of a "New ZIM" entity to retain key operations and interests in Israel. The transaction is subject to regulatory, shareholder, and governmental approvals, with labor strikes and Israel's golden share considerations in focus. ZIM operates as a global container shipping company, and this deal places it at the center of one of the larger consolidation moves in...

Element Solutions (ESI) just wrapped up FY 2025 with fourth quarter revenue of US$676.2 million and basic EPS of US$0.03, alongside trailing twelve month revenue of US$2.6 billion and EPS of US$0.79 that sit against a net profit margin of 7.5%. Over recent quarters the company has seen revenue move from US$593.7 million and EPS of US$0.40 in Q1 2025 to US$676.2 million and EPS of US$0.03 in Q4 2025, while the last 12 months also include a US$59.0 million one off gain and a P/E of 42.9x that...

If you are wondering whether Vistra's current share price really reflects its value, you are not alone. That is exactly what this article will unpack. Vistra closed at US$170.57, with returns of 6.5% over the last 7 days, 2.4% over 30 days, 3.2% year to date, 1.3% over 1 year and a very large return over 3 and 5 years that is close to 7x. Recent headlines around Vistra have focused on its position in the US utilities sector, including market interest in how it is managing its generation...

Apogee Therapeutics recently presented at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 in New York, highlighting its pipeline to investors and industry peers. Analyst commentary following Sanofi’s Phase 3 amlitelimab data framed the earlier selloff in Apogee shares as an overreaction, emphasizing that APG279’s prospects remain intact despite a more crowded competitive field. We’ll now examine how this reassessment of APG279’s outlook, following the Sanofi data reaction,...

Ares Management Corporation has already reported fourth-quarter 2025 revenue of US$1,504.92 million and net income of US$54.25 million, alongside full-year revenue of US$5,601.48 million and net income of US$527.36 million, while declaring higher quarterly dividends on both its common and preferred shares. Together with management’s recent conference remarks outlining record capital deployment, expansion in private credit and digital infrastructure, and clearer earnings growth targets, these...

In February 2026, Extreme Networks announced that its E-Rate-eligible Extreme Platform ONE and related fabric, Wi‑Fi 7, and switching solutions are now available to help K‑12 schools and public libraries modernize and automate their networks. An interesting angle for investors is how packaging these AI‑driven, education‑focused products with E-Rate support tools could deepen Extreme’s presence in a recurring, budget-constrained customer base. We’ll now examine how this push into AI-powered,...

JBG SMITH Properties (JBGS) has capped FY 2025 with fourth quarter revenue of US$127.7 million, a basic EPS loss of US$0.75, and funds from operations of US$13.9 million in losses, setting a cautious tone around earnings quality. The company has seen quarterly revenue move from US$130.4 million in Q4 2024 to US$127.7 million in Q4 2025. Trailing twelve month revenue sits at US$498.6 million and EPS over the same period is a loss of US$2.06, which keeps the focus squarely on how efficiently...

Newell Brands (NWL) is back in focus after reporting fourth quarter and full year 2025 results that included higher net losses, larger impairment charges on acquired intangible assets, and cautious net sales guidance for 2026. See our latest analysis for Newell Brands. The share price has moved to US$4.74, with a 90 day share price return of 46.75% and a year to date share price return of 27.42%, even though the 1 year total shareholder return is a 27.69% loss. Recent momentum therefore...

Dole Specialty Ingredients has recently expanded its upcycled tropical fruit ingredients business, working with partners such as Givaudan to supply clean-label, functional solutions across key Asian markets including Japan, Korea, China, and Malaysia. This move highlights Dole’s push into higher-value, sustainability-focused ingredients where it provides both products and formulation support, rather than competing purely as a commodity supplier. Next, we’ll examine how Dole’s push into...

Humacyte (HUMA) is back in focus after presenting long term Symvess data from the V005 trial at the VESS 2026 Winter Meeting, highlighting durability, low infection rates, and sustained limb salvage in complex trauma cases. See our latest analysis for Humacyte. Humacyte’s recent Symvess data arrives after a mixed share price run, with a 7 day share price return of 6.93% but a 1 year total shareholder return of a 72.09% loss, which points to short term momentum rebuilding against a weak longer...

USANA Health Sciences (USNA) closed FY 2025 with Q4 revenue of US$226.2 million and a basic EPS loss of US$0.10, as net income excluding extra items came in at a loss of US$1.8 million. Over the last six reported quarters, revenue has moved between US$200.2 million and US$249.5 million, while quarterly basic EPS has ranged from a profit of US$0.56 to a loss of US$0.36, and trailing twelve month EPS stood at US$0.58 on revenue of US$925.3 million in Q4 2025. For investors, the key story this...

MKS (MKSI) has wrapped up FY 2025 with Q4 revenue of US$1.0b and basic EPS of US$1.60, alongside trailing twelve month revenue of US$3.9b and EPS of US$4.38 that sit against a 55.3% earnings lift over the past year. The company has seen quarterly revenue move from US$934m in Q4 2024 to US$1.0b in Q4 2025, while basic EPS shifted from US$1.35 to US$1.60 over the same period. Analysts are forecasting 27.9% annual earnings growth and higher net profit margins, keeping investor attention firmly...

Why Atkore Is On Investors’ Radar Today Atkore (ATKR) has drawn attention after recent share price moves, with the stock roughly flat over the past year but showing a gain over the past 3 months and a weaker month. Against that backdrop, investors are weighing the company’s value score of 3, recent financial results, and how its current price around $66.39 lines up with its fundamentals. See our latest analysis for Atkore. Atkore’s recent 14.58% three-month share price return contrasts with a...

NANO Nuclear Energy (NasdaqCM:NNE) reports progress toward licensing and commercial deployment of its KRONOS microreactor, including completion of key site characterization work. The company is advancing construction permit applications and licensing efforts in both the U.S. and Canada for its micro modular reactor. Recent private placements have increased financial resources to support KRONOS development, acquisitions, and potential global expansion. NANO Nuclear has entered a feasibility...

Mach Natural Resources (NYSE:MNR) is working through integration challenges tied to newly acquired oil assets in the Central Basin Platform. At the same time, the company has announced an increase in its quarterly cash distribution to unitholders. The combination of operational complexity and higher cash returns has drawn fresh attention from investors and analysts. Mach Natural Resources comes into this news with a recent unit price of $13.31 and a mixed return profile. The units are up...

If you are wondering whether Bloom Energy's recent share price makes sense, the key question is how that price stacks up against the underlying value of the business. The stock closed at US$145.32, with a 7 day return of a 2.3% decline and a 30 day return of a 2.8% decline, while the year to date return is 47.2% and the 1 year return is 458.5%. Recent headlines around Bloom Energy have focused on its role in cleaner power solutions and ongoing interest from investors who follow the energy...

If you are wondering whether SailPoint is attractively priced or just a value trap, this article is here to walk you through what the current price might be telling you. SailPoint shares last closed at US$15.65, after a 2.6% gain over the past week, although the stock shows declines of 14.3% over 30 days, 17.4% year to date and 36.8% over the past year. Recent coverage around SailPoint has focused on its position in identity security software and how investors are weighing that role against...

In recent updates, Spyre Therapeutics outlined its 2026 plans, highlighting accelerated timelines for six proof-of-concept readouts, including the SKYLINE ulcerative colitis trial completing enrollment earlier than initially expected, and confirmed that the SKYWAY basket trial remains on schedule for later-stage data. The company also recently appointed Kate Tansey Chevlen as Chief Commercial Officer, signaling a growing emphasis on commercial readiness alongside its advancing inflammatory...

Lamb Weston Holdings (NYSE:LW) has appointed Jan Eli B. Craps as Executive Chair. The company has named James D. Gray as its new Chief Financial Officer. These appointments mark a significant leadership shift that may influence future priorities at Lamb Weston. Lamb Weston Holdings, trading at around $48.18 per share, is undergoing a meaningful reset at the top just as investors are weighing mixed recent performance. The stock is up 11.2% over the past 30 days and 13.9% year to date, but it...

In recent weeks, KKR & Co. Inc. reported fourth-quarter 2025 revenue of US$5,739.31 million and net income of US$1,145.91 million, affirmed a quarterly dividend of US$0.185 per share, and saw a director purchase 50,000 shares amid continued expansion in data centers, logistics real estate and sports investing. Together, the insider buying, record assets under management exceeding US$740 billion, and pursuit of assets like Ausgrid’s Plus ES highlight KKR’s emphasis on scaling fee-generating...

If you are wondering whether AngloGold Ashanti at around US$106 per share still offers value after a strong run, this article will walk through what the current price might imply. The stock has had a mixed short term patch, with a 2.2% decline over the last 7 days, a 7.2% gain over 30 days, and returns of 24.0% year to date and 246.5% over the past year, while the 3 year return is very large and the 5 year return is more than 4x. Recent coverage has focused on AngloGold Ashanti's move to the...